Nidanilimab (Synonyms: CAN04; Anti-IL-1RAP/IL-1R3 Reference Antibody (nidanilimab)) |
| Catalog No.GC69561 |
Nidanilimab (CAN04) is a fully humanized monoclonal antibody against IL1RAP, with a Kd value of 1.10 pM. Nidanilimab blocks the signaling pathways of IL1α and IL1β, and stimulates the immune system to destroy tumor cells. Nidanilimab can be used for research on non-small cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2171061-85-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Nidanilimab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Nidanilimab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *